About Us
Services & Solutions
Medicinal Chemistry Parallel Synthesis Peptide Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Toxicity In Rodents, Dogs and Monkeys Large Molecule Development and Bioanalysis
Assay Development Assay Platform Technologies Biochemical Assays Cellular Assays Ligand Binding Assays Protein Science Fragment Based Drug Discovery (FBDD) Surface Plasmon Resonance (SPR) Biologics
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models ELISA Assays In Vitro Assays
Immunology & Inflammation Metabolic MASH Mouse Models Respiratory Neuroscience Safety Pharmacology
Process R&D Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment Scale Up Synthesis Synthetic and Scale Up Chemistry Drug Substance Manufacturing
Kilo and Pilot Scale Production RSM and Intermediates Manufacturing QA EHS
Preformulation Formulation, Analytical, and Process Development Hot Melt Extrusion Spray Dried Dispersion Amorphous Solid Dispersion Bioavailability Enhancement Modified Release Drug Product Manufacturing Clinical Manufacturing
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact Us
×

INSIGHTS

Home News & Resources Insights

Fierce Pharma JPM Week – Interview: How Does the CRDMO Model Accelerate New Drug Development?

February 13, 2025
Share:

During 2025 Fierce Pharma JPM Week, Dr. Armin Spura, CEO of BioDuro was interviewed by Dr. Kurt Nielsen (Managing Partner, Expert Insights Consulting) as part of the Fierce Pharma fire-side chat series. Dr. Spura shares his perspective alongside other pharmaceutical leaders from the biotech and top CDMO sectors on constant innovation and accelerating change in the CDMO industry. He also outlined strategies to deliver accelerated translational science, efficient scale-up, and a fast path to first-in-human trials, while providing insights on:

• Describing the evolution of the industry landscape and future trends 

• Enhancing speed and efficiency in drug development 

• Navigating current geopolitical challenges 

• Addressing the complexities of drug development—from integrated platforms to scientific excellence, quality, and robust data/IP protection


Watch the full interview below:

Company News Events Insights Webinars Virtual Tours
Subscribe to BioDuro
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization
Services & Solutions

Chemistry

DMPK

Biology

Oncology

Pharmacology

Drug Substance

Drug Product

Platforms

Peptide

Compound Management

PROTAC Drug Discovery

Solution Engine

Integrated Drug Discovery

IND Enabling

DNA-Encoded Library

MASH Mouse Models

About Us

News & Resources

Careers

Contact Us

© 2025 BioDuro. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all